S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

(SCR) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
-0.20 (-0.87 %)
(As of 03/5/2021 12:00 AM ET)
Today's Range
Now: $22.80
50-Day Range
MA: $7,231.60
52-Week Range N/A
Volume858,942 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Simcere Pharmaceutical Group (Simcere) is a holding company. The Company principally engaged in the research, development, manufacture and distribution of pharmaceutical and vaccine products in the People's Republic of China. Company markets and sells its products directly or indirectly to approximately 1,405 pharmaceutical distributors who in turn sell these products to other distributors, hospitals and retail pharmacies throughout China. As of March 31, 2013, the Company also had over 11 product candidates in various stages of development, including treatments for cancer and cardiovascular diseases. In December 2013, Simcere completed the merger contemplated by the previously announced Agreement and Plan of Merger among the Company, Simcere Holding Limited (Parent) and Simcere Acquisition Limited (Merger Sub), and as a result of the merger, the Company became a wholly owned subsidiary of Parent.


See More Headlines

Industry, Sector and Symbol

Industry N/A
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.44 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Receive SCR News and Ratings via Email

Sign-up to receive the latest news and ratings for SCR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

(SCR) (NYSE:SCR) Frequently Asked Questions

What stocks does MarketBeat like better than (SCR)?

Wall Street analysts have given (SCR) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but (SCR) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What other stocks do shareholders of (SCR) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (SCR) investors own include Resideo Technologies (REZI), Cheniere Energy (LNG), Garrett Motion (GTX), Workday (WDAY), (WX) (WX), Vertiv (VRT), AT&T (T), The Bank of Nova Scotia (BNS) and Bank of Montreal (BMO).

When did (SCR) IPO?

(SCR) raised $183 million in an IPO on Thursday, February 25th 2021. The company issued 5,000,000 shares at $36.52 per share. Morgan Stanley, Credit Suisse, Canaccord Genuity and Macquarie Cap;ital acted as the underwriters for the IPO.

What is (SCR)'s stock symbol?

(SCR) trades on the New York Stock Exchange (NYSE) under the ticker symbol "SCR."

What is (SCR)'s stock price today?

One share of SCR stock can currently be purchased for approximately $22.80.

What is (SCR)'s official website?

The official website for (SCR) is www.simcere.com.

Where are (SCR)'s headquarters?

(SCR) is headquartered at No.699-18 Xuan Wu Avenue Xuan Wu District, NANJING, JNG 210042, China.

How can I contact (SCR)?

(SCR)'s mailing address is No.699-18 Xuan Wu Avenue Xuan Wu District, NANJING, JNG 210042, China. The healthcare company can be reached via phone at +86-25-85566666.

This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.